Purpose
These guidelines aim to standardize the practice of blood transfusion, ensuring safety, effectiveness, and proper utilization of blood products across healthcare facilities.
Scope
Applicable to all healthcare providers involved in transfusion practices, including clinicians, nurses, and laboratory personnel.
1. Indications for Blood Transfusion
Blood transfusion should be considered when the benefits outweigh the risks, based on clinical evaluation and laboratory findings. Common indications include:
- Anemia: Symptomatic anemia unresponsive to other treatments, hemoglobin < 7 g/dL in stable patients, or < 8 g/dL in those with cardiovascular disease.
- Acute Blood Loss: More than 30% of blood volume lost, or if hemodynamic instability persists despite fluid resuscitation.
- Specific Conditions: Hematologic malignancies, bone marrow failure syndromes, and conditions requiring chronic transfusion support.
2. Types of Blood Products
- Whole Blood: Rarely used, primarily in cases of massive hemorrhage.
- Red Blood Cells (RBCs): Used for anemia or acute blood loss.
- Platelets: Indicated for thrombocytopenia or platelet dysfunction.
- Fresh Frozen Plasma (FFP): For coagulopathies, massive transfusions, or liver disease.
- Cryoprecipitate: For fibrinogen deficiencies, DIC, or massive bleeding.
3. Pre-Transfusion Procedures
- Patient Assessment: Evaluate clinical indications, history of transfusion reactions, and need for premedications.
- Informed Consent: Explain risks, benefits, and alternatives; obtain written consent.
- Crossmatch and Compatibility Testing: Ensure blood type compatibility; use type-specific or O-negative RBCs in emergencies.
4. Transfusion Administration
- Identification: Confirm patient identity and product details (unit number, blood type) before transfusion.
- Rate of Administration: Start slowly, monitor for reactions. Adjust rate based on patient condition and product type:
- RBCs: 1 unit over 1.5–3 hours.
- Platelets/FFP: Rapid infusion over 15–30 minutes.
- Monitoring: Observe vitals before, during, and after transfusion. Look for signs of transfusion reactions (fever, chills, rash, dyspnea, hypotension).
5. Management of Transfusion Reactions
- Mild Reactions: (e.g., febrile non-hemolytic) Stop transfusion temporarily, administer antipyretics or antihistamines.
- Severe Reactions: (e.g., anaphylaxis, acute hemolytic reaction) Stop transfusion immediately, provide supportive care (IV fluids, oxygen, medications), and notify the transfusion service.
6. Documentation
Ensure accurate documentation of:
- Indication for transfusion
- Type and volume of product administered
- Patient monitoring and vital signs
- Any adverse reactions and interventions taken
7. Post-Transfusion Follow-Up
- Lab Monitoring: Check hemoglobin, hematocrit, platelet count, or coagulation profile as needed.
- Patient Observation: Continue monitoring for delayed reactions, such as delayed hemolytic reactions or transfusion-associated graft-versus-host disease (TA-GVHD).
Conclusion
Adhering to these guidelines ensures a standardized approach to blood transfusion, enhancing patient safety and treatment outcomes. Regular training and updates on transfusion practices are recommended for all healthcare providers.